Translate
Violation Detail
Standard Cited: 19101030 F03 II A Bloodborne pathogens.
Inspection Nr: 1194099.015
Citation: 01003
Citation Type: Serious
Abatement Date: 05/31/2017 2
Initial Penalty: $12,675.00
Current Penalty: $9,000.00
Issuance Date: 04/10/2017
Nr Instances: 3
Nr Exposed: 44
Related Event Code (REC): C
Gravity: 10
Report ID: 0524200
Contest Date:
Final Order: 05/04/2017
Emphasis:
| Type | Latest Event | Event Date | Penalty | Abatement Due Date | Citation Type | Failure to Abate Inspection |
|---|---|---|---|---|---|---|
| Penalty | I: Informal Settlement | 05/04/2017 | $9,000.00 | 05/31/2017 | Serious | |
| Penalty | Z: Issued | 04/10/2017 | $12,675.00 | 04/20/2017 | Serious |
Text For Citation: 01 Item/Group: 003 Hazard:
29 CFR 1910.1030(f)(3)(ii)(A): The post-exposure evaluation and follow-up of an exposure incident did not include testing the source individual's blood as soon as feasible and after consent was obtained in order to determine HBV and HIV infectivity: a) Octapharma Plasma, Inc., Northlake, IL- On or about October 27, 2016, the employer did not ensure that the post exposure evaluation and follow up, following a needlestick injury included the testing of the source individual as soon as feasible. The test results were not received until 5 days after the injury occurred. No rapid HIV testing was performed in accordance with the current US Public Health Service Guidelines. In accordance with 29 CFR 1903.19(d), abatement certification is required for this violation (using the CERTIFICATION OF CORRECTIVE ACTION WORKSHEET), and in addition, documentation demonstrating that abatement is complete must be included with your certification. This documentation may include, but is not limited to, evidence of the purchase or repair of the equipment, photographic or video evidence of abatement, or other written records.